Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0370220120560040248
Yakhak Hoeji
2012 Volume.56 No. 4 p.248 ~ p.253
Inhibitory Effects on Platelet Aggregation and Blood Coagulation by Concurrent Administration of Trifusal and Ibudilast
Hwang In-Young

Sohn Yoon-Ah
Hwang Seon-A
Koo Yean-Kyoung
Kim Sun-Young
Yoon Hye-Sook
Kwon Soon-Kyoung
Jeong Choon-Sik
Abstract
This study aims to develop a novel regimen for enhanced efficacy and reduced side effect in inhibiting platelet aggregation and blood coagulation by concurrent administration of triflusal and ibudilast as anticoaggulants. The result shows this combination of triflusal and ibudilast (300~500 ¥ìM, respectively) has additive effect in inhibiting platelet aggregation and blood coagulation over the administration of truflusal or ibdilast as a single treatment. This pharmaceutical composition is expected to be useful for the prevention or treatment of various diseases and symptoms, for example, ischemic heart disease, ischemic cerebral infarction, arteriosclerosis, and thrombosis caused by the insertion of a stent.
KEYWORD
triflusal, ibudilast, platelet aggregation, blood coagulation
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)